UBS Maintains Buy on BrightSpring Health, Raises Price Target to $85

Benzinga · 07/08 18:18
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $63 to $85.